Clinical Trial Update: Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin for Treatment-Naïve Hemodialysis Patients With Chronic Hepatitis C [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating pegylated interferon alfa-2a plus low-dose ribavirin in treatment-naïve hemodialysis patients with chronic hepatitis C.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Pegylated interferon alfa-2a (Peginterferon alfa-2a)
• Ribavirin (ribavirin)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Chronic Hepatitis C | Phase 4 | Status: COMPLETED | Results posted: 2013-12-13